Feiz-Haddad Mohammad-Hossein, Moradkhani Mohammad-Ali, Sefat Farshid, Ali S A
Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Department of Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Department of Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Exp Parasitol. 2024 Dec;267:108857. doi: 10.1016/j.exppara.2024.108857. Epub 2024 Nov 8.
Cutaneous leishmaniasis (CL), a zoonotic and neglected disease, is prevalent in numerous regions, particularly in tropical and sub-tropical countries. In Iran, endemic foci of leishmaniasis exist in specific regions, with zoonotic cutaneous leishmaniasis (ZCL) caused by Leishmania major being common in most rural areas. Toll-like receptors (TLRs) play a crucial role in both innate and adaptive immunities, and the investigation of TLR2 rs5743708 and TLR4 (rs4986790 and rs4986791) polymorphisms in parasitic diseases can have significant implications for patient treatment. In the present study, a total of 88 leishmaniasis patients using the patients' lesions from Khuzestan province health-treatment centers, Iran, including 50 cases (56.8%; Central region) and 38 cases (43.2%; Western region) underwent examination between the years 2022 and 2023. Two direct smears from the lesions of each patient were prepared and one of the smears was stained with Giemsa for parasitological examination. Among the 88 patients, the highest frequency was observed in the 21-30 years' age group (35.2%), while the lowest was in the 11-20 years' age group (10.2%). No statistically significant relationship was found between gender and age (P > 0.05). Following disease confirmation via microscopic examination, TLR2 rs5743708 and TLR4 (rs4986790 and rs4986791) polymorphisms in the patients were assessed using PCR-RFLP. Fragments of 264, 249, and 406 base pairs were successfully amplified, targeting the TLR2 and TLR4 genes, respectively. Out of the 88 leishmaniasis patients, 14 cases (15.9%) exhibited polymorphisms. Notably, all individuals in the polymorphism group carried both the TLR2 rs5743708 homozygous and the TLR4 rs4986791 heterozygous genotype combinations. There were no observations of TLR2 rs5743708 heterozygous, TLR4 rs4986790 heterozygous and homozygous and TLR4 rs4986791 homozygous genotypes within the polymorphism group. Biopsies from lesions for all contributors were prepared for histopathological examination. All patients with polymorphism showed larger lesions than patients without polymorphism (P < 0.05). Histophatological study showed abnormal cases in patients with polymorphism including mild hyperkeratosis, mild acanthosis, focal parakeratosis in the epithelium surface and mild hyperpigmentation of melanocytes in the basal layer. Furthermore, a strong infiltration of immune cells such as PMNs and a small number of lymphocytes was observed in the epidermal region of patients with polymorphisms. There was no statistically significant relationship between age and the quantity of lesions (P > 0.05). Additionally, some regions of the epidermal surface layer displayed pustule formation in patients with polymorphisms. No significant difference was discerned in the dermal layers of patients with polymorphisms compared to other patients. Considering that all patients with polymorphisms concurrently had TLR2 rs5743708 homozygous and TLR4 rs4986791 heterozygous genotype combinations, the anomalies observed in conjunction with histological changes in the skin lesions of patients with CL may plausibly be linked to the polymorphisms. Nonetheless, a more expansive dataset involving a larger population is imperative to comprehensively elucidate the pathogenesis of the Leishmania parasite and the potential impact of TLR2 rs5743708 and TLR4 (rs4986790 and rs4986791) gene polymorphisms in individuals afflicted with CL across diverse geographical locales.
皮肤利什曼病(CL)是一种人畜共患的被忽视疾病,在许多地区流行,特别是在热带和亚热带国家。在伊朗,利什曼病的地方性疫源地存在于特定地区,由硕大利什曼原虫引起的人畜共患皮肤利什曼病(ZCL)在大多数农村地区很常见。Toll样受体(TLR)在先天免疫和适应性免疫中都起着关键作用,对寄生虫病中TLR2 rs5743708和TLR4(rs4986790和rs4986791)多态性的研究对患者治疗可能具有重要意义。在本研究中,2022年至2023年间,共对88例来自伊朗胡齐斯坦省卫生治疗中心的利什曼病患者进行了检查,这些患者使用了自身的病变样本,其中包括50例(56.8%;中部地区)和38例(43.2%;西部地区)。为每位患者的病变部位制备了两张直接涂片,其中一张涂片用吉姆萨染色进行寄生虫学检查。在这88例患者中,21 - 30岁年龄组的频率最高(35.2%),而11 - 20岁年龄组的频率最低(10.2%)。未发现性别与年龄之间存在统计学显著关系(P > 0.05)。通过显微镜检查确诊疾病后,使用聚合酶链反应 - 限制性片段长度多态性(PCR - RFLP)评估患者的TLR2 rs5743708和TLR4(rs4986790和rs4986791)多态性。分别成功扩增出靶向TLR2和TLR4基因的264、249和406个碱基对的片段。在88例利什曼病患者中,14例(15.9%)表现出多态性。值得注意的是,多态性组中的所有个体均携带TLR2 rs5743708纯合子和TLR4 rs4986791杂合子基因型组合。多态性组中未观察到TLR2 rs5743708杂合子、TLR4 rs4986790杂合子和纯合子以及TLR4 rs4986791纯合子基因型。为所有参与者的病变部位制备活检样本进行组织病理学检查。所有具有多态性的患者的病变均比无多态性的患者大(P < 0.05)。组织病理学研究显示,具有多态性的患者存在异常情况,包括轻度角化过度、轻度棘层肥厚、上皮表面局灶性角化不全以及基底层黑素细胞轻度色素沉着。此外,在具有多态性的患者的表皮区域观察到大量免疫细胞如多形核中性粒细胞(PMN)和少量淋巴细胞的浸润。年龄与病变数量之间未发现统计学显著关系(P > 0.05)。此外,具有多态性的患者的表皮表层某些区域出现脓疱形成。与其他患者相比,具有多态性的患者的真皮层未发现显著差异。鉴于所有具有多态性的患者同时具有TLR2 rs5743708纯合子和TLR4 rs4986791杂合子基因型组合,CL患者皮肤病变的组织学变化所伴随的异常情况可能合理地与这些多态性相关。然而,需要更广泛的数据集和更大的人群来全面阐明利什曼原虫的发病机制以及TLR2 rs5743708和TLR4(rs4986790和rs4986791)基因多态性对不同地理区域CL患者的潜在影响。